Hives News and Research

RSS
Hives (or Urticaria) are a kind of skin rash notable for dark red, raised, itchy bumps. Hives are frequently caused by allergic reactions; however, there are many non-allergic causes.
Researchers observe worrisome increase in anaphylaxis rate

Researchers observe worrisome increase in anaphylaxis rate

Vanderbilt's A.S.A.P sees increase in number of patients treated for alpha-gal syndrome

Vanderbilt's A.S.A.P sees increase in number of patients treated for alpha-gal syndrome

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

NIH researchers identify genetic mutation responsible for vibratory urticaria

NIH researchers identify genetic mutation responsible for vibratory urticaria

Simple method to purify cashew allergens could help scientists better understand allergic reactions

Simple method to purify cashew allergens could help scientists better understand allergic reactions

American Academy of Dermatology releases Chronic Hives Patient App

American Academy of Dermatology releases Chronic Hives Patient App

Majority of people not allergic to intravenous penicillins, say ACAAI allergists

Majority of people not allergic to intravenous penicillins, say ACAAI allergists

New research shows siblings of children with food allergies have sensitivity, but not true allergy

New research shows siblings of children with food allergies have sensitivity, but not true allergy

Nucala (mepolizumab) approved for treatment of asthma patients

Nucala (mepolizumab) approved for treatment of asthma patients

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Boehringer Ingelheim, Lilly announce availability of Synjardy tablets in U.S. pharmacies

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Repatha (evolocumab) injection gets FDA approval for high cholesterol

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

FDA grants 12-year exclusivity to RUCONEST (C1 esterase inhibitor [recombinant])

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Shire enters into agreement with Sanquin for CINRYZE

Shire enters into agreement with Sanquin for CINRYZE

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

New research reveals why some kids can have severe allergic reaction hours later

New research reveals why some kids can have severe allergic reaction hours later

Galderma obtains FDA approval for Restylane Lyft to restore structure to the cheeks and midface area

Galderma obtains FDA approval for Restylane Lyft to restore structure to the cheeks and midface area

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.